Outcome After Arthroscopic Treatment of Patients in Horsens and Aarhus With FemoroAcetabular Impingement: the HAFAI-cohort

Brief Summary

Detailed Description

Introduction Femoral acetabular impingement (FAI) is caused by an abnormality in the acetabular shape or orientation (Pincer-type) by a shape abnormality in the proximal femur (Cam-type) or by a mix of the two conditions. FAI causes repeated minor damage to the labrum and edge of the acetabulum. The damage to the joint is proposed to lead to early osteoarthritis (OA) of the hip, but whether FAI is a cause or result of OA is discussed. Surgery can reduce symptoms caused by Cam or Pincer impingement and may prevent future damage to the hip joint. However, different surgical techniques are used, and only few long-term studies of the surgery exist. The latest reviews conclude that 1) the effectiveness of the surgery is not clear, 2) it is not clear how surgery affects functional performance for the patients and 3) it is unknown how surgery for FAI affects the patients in a long-term perspective. Material and methods Patients: Inclusion criteria * Planned hip arthroscopic treatment at Horsens Regional Hospital by Consultant Bent Lund * A diagnosis of CAM and/or pincer impingement * For patients with Cam, an alpha angle \> 55 degrees on an anterior/posterior (AP) standing radiograph * For patients with Pincer a center edge angle \> 25 degrees on an AP radiograph * No signs of retroversion in the lower 2/3 of the hip joint on an AP radiograph * No posterior wall sign on an AP radiograph * Osteoarthritis grade 0-1 according to Tönnis' classification * Lateral Joint space width of \> 3 mm * Age between 18 and 50 years Exclusion criteria * Previous hip operations of the included hip * Persons with FAI secondary to other hip conditions such as Calvé Perthes and epiphysiolysis. * Alloplastic surgery at the hip, knee or ankle region (both legs) * Neurological diseases * Cancer * Inability to speak or understand Danish * Pregnancy at the time of inclusion Control persons (healthy volunteers) Thirty gender and age-matched persons with no known hip, knee or ankle region problems will be included as controls. Primary outcome measures * Hip and pelvis kinetics and kinematics during walking, stair climbing, stepping, sit-to-stand and drop jump * Hip extensor and flexor maximal muscle strength during isometric and isokinetic contractions * Hip extensor and flexor rate of force development during isometric contraction * Objectively measured daily physical activities during 5 days * Hip- related self-reported health measured with the Copenhagen Hip and Groin Outcome Score Secondary outcome measures * Knee and trunk kinetics and kinematics during walking, stair climbing, stepping, sit-to-stand and jump * Hip extensor and flexor rate of force development during isometric contraction * Self-selected walking speed * Presence of intra-articular pathology examined with FABER and impingement tests * Visual analog scale, pain * Patient expectations * Reasons for choosing surgery * Patient global treatment outcome * Patient-acceptable symptom state * EQ5D-Visual analog scale * Failure * Re-operations and injections during the first year after surgery * Self-reported present sports activities * Time spend at preferred sports activity present * Time spend at sports activities during childhood * Sports activities during childhood * Return to sports activities * Education * Employment * Smoking habits * Alcohol intake * Intake of analgesia * Comorbidities Other Pre-specified Outcome Measures: * Alpha angle * Wiberg's center-edge (CE) angle * Tönnis' acetabular index (AI) * Retroversion of acetabulum * The position of the femoral head in relation to the neck * Osteoarthritis grade according to Tönnis' classification * Lateral hip joint space width * Information about the surgical procedure immediately * Deviation from rehabilitation program * Duration of pain * Body Mass Index * Body fat percentage * Age Procedure Patients scheduled for hip arthroscopic treatment at Horsens Regional Hospital will receive written and verbal information about the study and after informed consent included consecutively. After agreeing to participate, the patients will have a pre-operative CT-scan of the included hip. At Aarhus University, patients will have a clinical examination session including measurement of height, weight and fat percentage. They will have their hip extensor and flexor muscle strength assessed in an isokinetic dynamometer and perform walking, stair climbing, stepping, sit to stand and a drop jump with 3D-motion capture. Patients will complete the HAGOS-questionnaire together with the other pre specified self-reported measures described. After all tests are completed, the patients will be instructed in wearing a 3-axial accelerometer for five days, attached to the thigh of the non-affected leg to monitor daily physical activity. At a three, six and nine month follow-up patients will complete HAGOS, pain scores and self-reported measures of return to sport, work, re-operations and injections after surgery and EQ5D-Visual analog scale. At a one year follow up, preoperative measures will be repeated. Further, at six month and one year follow up the patients will report fulfillment of expectations, patient global treatment outcome and patient willingness to repeat surgery. All controls will meet at Aarhus University for a single assessment of the same measures as the patients except from CT-scans and outcome measures related to the surgery. Statistics Patients and controls will be compared with multiple regression analysis adjusted for age, gender and body weight if the assumptions for the model is met. If not, they will be compared using un-paired non-parametric statistics. The longitudinal measures of the patients pre, three, six, nine month and one year after surgery will be evaluated in a paired set-up. Further analyses Based upon the preoperative CT-scan, the patients will be split into subgroups: FAI will be classified as Cam (alpha angle \> 55˚), Pincer (center edge angle \> 25˚ from CT and AP radiograph and/or crossing sign and ishial spine sign) and Mixed when there is a combination of Cam and Pincer. We will investigate how these subgroups affects outcome measures. Further, we will investigate how demographics, preoperative and postoperative muscle strength and pain affects the results of the surgery and rehabilitation procedure. Sample size The primary end point for the study is one year after surgery. For the muscle strength assessment, sample size is based upon pre- and post-operative values from Casartelli et al. (2) with a level of significance of 0.05 and a power of 90 %, the patient group should consist at least 53 persons. Taking possible drop-outs in account our goal is to include 60 patients. We will include 30 controls persons for comparisons. Ethics The Danish Biomedical Research Ethics Committee, Central Denmark Region (1-10-72-239-14) and the Danish Data Protection Agency have approved the project (1-16-02-499-14). Economy and dissemination Financial support will be applied for at internally at our institution and externally at various foundations. Both positive, negative and inconclusive results will be published in international journals and presented at conferences. References 1. Mannion AF, Impellizzeri FM, Naal FD, Leunig M: Fulfilment of patient-rated expectations predicts the outcome of surgery for femoroacetabular impingement. Osteoarthritis and Cartilage 2013, 21:44-50. 2. Casartelli NC, Maffiuletti NA, Item-Glatthorn JF, Impellizzeri FM, Leunig M: Hip muscle strength recovery after hip arthroscopy in a series of patients with symptomatic femoroacetabular impingement. Hip international : the journal of clinical and experimental research on hip pathology and therapy 2014:0. 3. Paulsen A, Roos EM, Pedersen AB, Overgaard S. Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. Acta orthopaedica. 2014;85(1):39-48.

Primary Outcomes

Secondary Outcomes

• Hip extensor and flexor rate of force development during isometric contraction(Preoperatively (Approx. in the time frame 0-10 weeks before surgery) and one year after surgery)
• Self-selected walking speed(Preoperatively (Approx. in the time frame 0-10 weeks before surgery) and one year after surgery)
• Time spend at sports activities during childhood(Preoperatively (Approx. in the time frame 0-10 weeks before surgery))
• Employment(Preoperatively (Approx. in the time frame 0-10 weeks before surgery))
• Visual analog scale, pain(Preoperatively (Approx. in the time frame 0-10 weeks before surgery) and one year after surgery)
• Patient-acceptable symptom state(Six month and one year after surgery)
• EQ5D-Visual analog scale(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), 6 month and one year after surgery)
• Self-reported present sports activities(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), 3 month, 6 month, 9 month and one year after surgery)
• Education(Preoperatively (Approx. i the time frame 0-10 weeks before surgery))
• Knee and trunk kinetics and kinematics during walking, stair climbing, stepping, sit-to-stand drop jump(Preoperatively (Approx. in the time frame 0-10 weeks before surgery) and one year after surgery)
• Presence of intra-articular pathology examined with FABER and impingement tests(Preoperatively (Approx. in the time frame 0-10 weeks before surgery) and one year after surgery)
• Patient expectations(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), 6 month and one year after surgery)
• Failure(One year after surgery)
• Re-operations and injections during the first year after surgery(3 month, 6 month, 9 month and one year after surgery)
• Sports activities during childhood (age < 18)(Preoperatively (Approx. in the time frame 0-10 weeks before surgery))
• Reasons for choosing surgery(Preoperatively (Approx. in the time frame 0-10 weeks before surgery))
• Patient global treatment outcome(Six month and one year after surgery)
• Time spend at preferred sports activity(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), 3 month, 6 month, 9 month and one year after surgery)
• Smoking habits(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), one year after surgery)
• Alcohol intake(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), one year after surgery)
• Intake of analgesia(Preoperatively (Approx. in the time frame 0-10 weeks before surgery), 3 month, 6 month, 9 month and one year after surgery)
• Comorbidities(Preoperatively (Approx. in the time frame 0-10 weeks before surgery))